콘텐츠로 건너뛰기
Merck
  • [Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].

[Current views on diagnostic standards and treatments with L-thyroxine of single non-toxic thyroid nodules or multinodular non-toxic goiter].

Wiadomosci lekarskie (Warsaw, Poland : 1960) (2002-08-17)
A Lewiński
초록

The present opinions on the therapy with L-thyroxine (L-T4) of single non-toxic thyroid nodules, as well as of multinodular non-toxic goitre are rather divergent. This treatment is based on the suppression of TSH secretion from the pituitary. There are no doubts that FNAB performance is the first and--at the same time--the most significant diagnostic procedure in the case of thyroid structural lesions (nodules, goitre, thyroiditis). FNAB performance should--by all means--precede the beginning of L-T4 application for the treatment of thyroid nodules. The simplicity, clearness and high efficacy, with comparable results in each case, are the core of good diagnostic algorithm. Unfortunately, non all diagnostic algorithms concerning thyroid nodules and multinodular goiter, fulfill these important criteria.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
L-Thyroxine, ≥98% (HPLC)
Sigma-Aldrich
L-Thyroxine, powder, BioReagent, suitable for cell culture
USP
Levothyroxine, United States Pharmacopeia (USP) Reference Standard
Supelco
L-Thyroxine (T4) solution, 100 μg/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Cerilliant®